Nominate an industry leader for recognition they deserve
24 September, 2013The 2013 Janssen Industry Excellence Awards close this Friday 27 September. This is the last chance in 2013 to nominate an individual or organisation that has made a significant contribution to the biotechnology industry.
Phosphagenics commences TPM/oxymorphone trial
20 September, 2013 by Dylan Bushell-EmblingPhosphagenics (ASX:POH) has started dosing volunteers in a phase I trial of pain patch candidate TPM/oxymorphone and aims to enter phase II in 1H14.
Pharmaxis to reduce board size to four
20 September, 2013 by Dylan Bushell-EmblingTwo Pharmaxis (ASX:PXS) independent directors have retired and the newly-restructured company is using the opportunity to shave down its board size.
Freehills adds new partner
20 September, 2013Freehills Patent Attorneys has appointed another a partner in their pharmaceutical and biotechnology practice.
BioDiem's BDM-I presented at antimicrobial meet
19 September, 2013 by Dylan Bushell-EmblingA poster presentation detailing the activity of BioDiem's (ASX:BDM-I) animicrobial BDM-I in nearly 70 fungal infections has been presented at an interscience conference.
Be a part of the first Australian world brain mapping congress: call for papers and registrations open
19 September, 2013For the first time in Australia, all disciplines involved in brain mapping and therapies will gather at the one conference when the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT Congress) comes to Sydney early next year.
Calzada files for US approval for NovoSorb in TNP
18 September, 2013 by Dylan Bushell-EmblingCalzada (ASX:CZD) has submitted an application with the US FDA for its NovoSorb wound dressings in procedures involving topical negative pressure (TNP).
SMART Arm wins CA grant for limb rehab device
18 September, 2013 by Dylan Bushell-EmblingStart-up SMART Arm will receive a grant worth $200K to help commercialise its eponymous upper limb rehabilitation device for stroke victims.
AusBiotech welcomes new Coalition ministry
17 September, 2013AusBiotech has welcomed the new Coalition ministry; in particular, the new Minister for Industry, Ian Macfarlane, who is returning to the portfolio he held from 2001 to 2007 when he was the Minister for Industry (Tourism and Resources).
Last call for nominations to the board of AusBiotech and 2013 Industry Excellence Awards
12 September, 2013Nominations will close shortly for candidates to nominate for the AusBiotech board of directors and for the Janssen 2013 Industry Excellence Awards, which recognise those who have made a significant contribution to the biotechnology industry.
SYNthesis med chem opens UK lab
10 September, 2013 by Dylan Bushell-EmblingAustralia-based CRO SYNthesis med chem has opened a UK facility to support its existing labs in Melbourne and Shanghai.
Australia’s first Tech Transfer Summit concludes with call for greater support for commercialisation
10 September, 2013TTS Australia 2013 brought together 150 leading tech transfer professionals from Australia and the international community to help build expertise and relationships that enable successful tech transfer - that which results in the translation of research into products to benefit our community.
Tailoring cancer drug dosage
10 September, 2013Scientists from Flinders University are collaborating with clinicians from Flinders Medical Centre to make a class of cancer drugs more effective by allowing patients to receive the dose that is best for them.
QRxPharma, FDA to discuss MoxDuo setback in October
09 September, 2013 by Dylan Bushell-EmblingQRxPharma (ASX:QRX) will meet with the US FDA in October to discuss the issues raised in the latest Complete Response Letter for dual-opioid drug MoxDuo.
pSivida to present at two US investor conferences
09 September, 2013 by Dylan Bushell-EmblingpSivida (ASX:PVA) will this week make presentations at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference.
